Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Benjamin Landry is General Counsel at Health Catalyst. OQRO lists 15 transactions filed with the SEC under this name, the latest on Nov 13, 2026, each linked to the official Form 4.
General Counsel
Disclosures on record
15
Companies involved
1
As of the latest filing on , Benjamin Landry reported holding 251,894 shares of Health Catalyst (HCAT), worth about $380K at the last close of $2 (Nov 13, 2026). In the last 12 months, Benjamin Landry sold $213K in 3 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Health Catalyst HCAT | 251,894 | 252K direct | $2 | $380K | Nov 12, 2026 |
Is this Benjamin Landry’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Health CatalystHCAT
15 disclosures · Dec 2024 – Nov 2026 · 8 sold
Nov 11, 2026Sold~$100Kdisclosed Nov 13
DetailsOfficial recordNov 12, 2026Sold~$41Kdisclosed Nov 13
DetailsOfficial recordSep 1, 202613Kdisclosed Sep 4
DetailsOfficial recordJun 1, 202614Kdisclosed Jun 4
DetailsOfficial recordMar 2, 202621Kdisclosed Mar 6
DetailsOfficial recordFeb 25, 2026289Kdisclosed Feb 28
DetailsOfficial recordFeb 25, 202616Kdisclosed Feb 28
DetailsOfficial recordFeb 26, 20266,317disclosed Feb 28
DetailsOfficial recordDec 5, 2025Sold~$72Kdisclosed Dec 10
DetailsOfficial recordDec 1, 202514Kdisclosed Dec 4
DetailsOfficial recordSep 5, 2025Sold~$21Kdisclosed Sep 9
DetailsOfficial recordJun 5, 2025Sold~$24Kdisclosed Jun 9
DetailsOfficial recordMar 6, 2025Sold~$63Kdisclosed Mar 10
DetailsOfficial recordJan 6, 2025Sold~$19Kdisclosed Jan 10
DetailsOfficial recordDec 6, 2024Sold~$160Kdisclosed Dec 10
DetailsOfficial recordBenjamin Landry has no open-market purchase on record since 2023. Sales in each of the last 4 years.
Benjamin Landry reported 0 open-market purchases and 14 sales since 2023; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $141K2×2 trades |
| 2025 | — | $199K5×5 trades |
| 2024 | — | $278K4×4 trades |
| 2023 | — | $39K3×3 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Nov 12, 2026, Benjamin Landry reported holding 251,894 shares of Health Catalyst (HCAT). At the last close of $2 on Nov 13, 2026, that is about $380K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Benjamin Landry reported 3 open-market sales worth $213K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Benjamin Landry has no open-market purchase on record since 2023. Sales in each of the last 4 years.
In SEC filings since 2023: no open-market purchase is on record; the latest open-market sale is from 2026.
Health Catalyst (HCAT), from 2023 to 2026: 0 purchases and 14 sales.
Benjamin Landry reported 0 open-market purchases and 14 sales here, 2023 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
